Anzeige
Mehr »
Freitag, 06.06.2025 - Börsentäglich über 12.000 News
Starke Zahlen: EBITDA bei 9 Mio.?€ - Startet jetzt die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2QCUH | ISIN: SE0014855029 | Ticker-Symbol: 8IM1
Düsseldorf
06.06.25 | 09:10
3,735 Euro
-0,93 % -0,035
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
IMPLANTICA AG SDR Chart 1 Jahr
5-Tage-Chart
IMPLANTICA AG SDR 5-Tage-Chart
RealtimeGeldBriefZeit
3,6703,86515:51
3,6703,86515:51

Aktuelle News zur IMPLANTICA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiImplantica announces that UK NICE has published positive recommendations for the RefluxStop procedure in the NHS public hospitals260VADUZ, Liechtenstein, June 4, 2025 /PRNewswire/ -- Implantica AG (publ.), providing the unique device RefluxStop for the treatment of acid reflux, announces that the world-renowned National...
► Artikel lesen
27.05.Implantica's RefluxStop stimulates intensive dialogue at DDW, the world's largest Digestive Disease conference, held in the U.S.431VADUZ, Liechtenstein, May 27, 2025 /PRNewswire/ -- Implantica AG (publ.) reports successful pre-launch activities in the U.S., pending FDA approval, with European real-world clinical evidence...
► Artikel lesen
IMPLANTICA Aktie jetzt für 0€ handeln
15.05.Bulletin from the Annual General Meeting of Implantica AG279VADUZ, Liechtenstein, May 15, 2025 /PRNewswire/ -- Today, May 15, 2025, the annual general meeting (the "AGM") of Implantica AG (publ) was held in Ruggell, Liechtenstein. The general meeting...
► Artikel lesen
09.05.Implantica publishes Interim Report January - March 2025 (Q1)311VADUZ, Liechtenstein, May 9, 2025 /PRNewswire/ -- Global expansion of RefluxStop Significant events in the first quarter of 2025 Received positive feedback from U.S. FDA on...
► Artikel lesen
06.05.Implantica announces 15th RefluxStop Center in Spain241VADUZ, Liechtenstein, May 6, 2025 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the unique device RefluxStop...
► Artikel lesen
02.05.Implantica presents the first quarter 2025 on May 9 at 15:00 CEST282VADUZ, Liechtenstein, May 2, 2025 /PRNewswire/ -- Implantica AG (publ) invites investors to a presentation of the first quarter 2025 at 15:00 CEST on May 9. The interim report for the first...
► Artikel lesen
25.04.Notice of Annual General Meeting of Implantica AG474VADUZ, Liechtenstein, April 25, 2025 /PRNewswire/ -- The depository receipt holders of Implantica AG, reg. no. FL-0002.629.889-3, are hereby invited to attend the annual general meeting to...
► Artikel lesen
23.04.Implantica opens a new RefluxStop center in a new region of Spain, addressing the fast-growing demand289VADUZ, Liechtenstein, April 23, 2025 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the unique device...
► Artikel lesen
15.04.Implantica publishes Annual Report 2024285VADUZ, Liechtenstein, April 15, 2025 /PRNewswire/ -- Implantica AG (publ), a med-tech company at the forefront of bringing advanced technology into the body, is publishing its annual report...
► Artikel lesen
10.04.Implantica announces a newly published real-world study from Germany reinforcing the excellent RefluxStop results423VADUZ, Liechtenstein, April 10, 2025 /PRNewswire/ -- Implantica AG (publ.), a MedTech company at the forefront of introducing advanced technology into the body, including the unique device...
► Artikel lesen
25.03.Implantica's RefluxStop garners strong interest at SAGES373VADUZ, Liechtenstein, March 25, 2025 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the unique device...
► Artikel lesen
19.03.Implantica announces further expansion of RefluxStop centers of excellence and patient access in Spain391VADUZ, Liechtenstein, March 19, 2025 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the unique device...
► Artikel lesen
14.02.Implantica publishes Year-end Report, January - December 2024 (Q4)372VADUZ, Liechtenstein, Feb. 14, 2025 /PRNewswire/ -- RefluxStop FDA Milestone Significant events in the fourth quarter Submitted extensive clinical Module 2 of the 3 module-process...
► Artikel lesen
13.02.Implantica announces positive feedback received from U.S. FDA of the RefluxStop PMA Module 2 submission373VADUZ, Liechtenstein, Feb. 13, 2025 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including a unique device RefluxStop...
► Artikel lesen
12.02.Implantica announces Module 1 is accepted and closed by FDA in the PMA application for RefluxStop1.592VADUZ, Liechtenstein, Feb. 12, 2025 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including a unique device RefluxStop...
► Artikel lesen
07.02.Implantica presents the Year-end Report (Q4 2024) on February 14 at 15:00 CET378VADUZ, Liechtenstein, Feb. 7, 2025 /PRNewswire/ -- Implantica AG (publ) invites investors to a presentation of the Year-end Report (Q4 2024) at 15:00 CET on February 14. The Year-end Report...
► Artikel lesen
06.02.Implantica announces onboarding of the world-leading La Paz University Hospital, Spain262VADUZ, Liechtenstein, Feb. 6, 2025 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the unique device...
► Artikel lesen
04.02.Implantica announces completion of first GI-focused RefluxStop educational meeting by a prestigious NHS Hospital in the UK263VADUZ, Liechtenstein, Feb. 4, 2025 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the unique device...
► Artikel lesen
09.01.Implantica announces new exceptional published data from the largest real-world study from Germany484VADUZ, Liechtenstein, Jan. 9, 2025 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the unique device...
► Artikel lesen
23.12.24Implantica announces the payment of share rewards based on the AGM approved share-based incentive program as a directed share issue of own shares of the company without consideration12
Weiter >>
42 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1